Delivery Order SPE2DB22D3004-SPE2DB24FPV41
- Not listed
- This federal contract award, valued at $3,418.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period extending through April 10, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,298.24, is a delivery order for the provision of Dupixent 300 mg/2 ml pen, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of April 24, 2025. The award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug...
- This federal contract award, valued at $16,404.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order for Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. The contract has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide...
- This federal contract award, valued at $20,602.38, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to supply Dupixent 300 mg/2 ml pens. The firm fixed price delivery order has a ceiling value of $13,291.90 and a period of performance through April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This award is part of a larger indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract, valued at $28,893.44, is a firm fixed price delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen 2 ml. The contract has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
- This federal contract award, valued at $10,912.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a performance period through April 11, 2024. This award is a firm fixed price delivery order and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is...
- This federal contract award, valued at $7,765.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, and is a delivery order contract type with a firm fixed price. The award has an ultimate completion date of April 27, 2023. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a...
- This federal contract award, valued at $36,914.39, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $2,257.96, is for the supply of Dupixent 300 mg/2 ml pens. The contract is a firm fixed price delivery order with a performance period through March 25, 2024. Amerisourcebergen Drug Corp holds a single-award indefinite delivery contract...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPV41Delivery Order
This federal contract award, valued at $6,609.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The current award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 4/1/24 |